Different mechanisms, different tolerability, different costs
Written by Lauren Lund, APRN-CNP Reviewed by Laurianne Scott, DO LAST UPDATED: Nov 11, 2024 Traveling can be stressful enough without the added concern of managing your medications, especially when you're on GLP-1 medications which are commonly used for weight loss
Identification of genes involved in the decrease of opacity using microarrays To identify the genes associated with the development of lens opacity induced by galactose and the effect of glutamate on opacity reduction, we cultured 2 samples (Control) for 4 and 6 days without galactose, 3 samples (Galactose) were cultured for 6 days in a medium containing galactose to induce opacity, and 2 samples (Glutamate) were cultured in a medium containing galactose for 3 days to induce opacity, followed by the addition of glutamate and an additional 3 days of culture for microarray analysis
For GLP-1 compounds, small dose changes can meaningfully change the draw volume
It is a small protein made of three amino acids